Literature DB >> 15542200

Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil.

Angela Pires Brandão1, Tânia Cristina de Oliveira, Maria Cristina de Cunto Brandileone, Jorge Emílio Gonçalves, Teresa Ikuko Yara, Vera Simonsen.   

Abstract

To evaluate the immunogenicity of 23-valent pneumococcal polysaccharide vaccine in 52 nursing homes residents aged > or = 60 years, IgG antibodies to serotypes 1, 5, 6B, and 8 were measured by ELISA and compared before, and 1 and 12 months following vaccination. A significant immunological response for all serotypes was observed at 1 month after vaccination. The mean increase in antibody concentration was highly variable and ranged from 1.6 to 2.7. After 1 year, the mean concentrations remained significantly higher than prior to vaccination for serotypes 1, 6B, and 8, although there was a decrease in all mean IgG concentrations. Antibody levels were higher in men than in women, before and after immunisation. Post-vaccination values tended to be lower among subjects aged >75 years. Reduction in IgG concentrations by 33% 1 year after vaccination suggests that revaccination of institutionalised elderly people may be needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542200     DOI: 10.1016/j.vaccine.2004.07.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

Review 1.  Sex and Gender Impact Immune Responses to Vaccines Among the Elderly.

Authors:  Ashley L Fink; Sabra L Klein
Journal:  Physiology (Bethesda)       Date:  2015-11

2.  Comparative immune responses of patients with chronic pulmonary diseases during the 2-year period after pneumococcal vaccination.

Authors:  Meng Chen; Yuki Hisatomi; Akitsugu Furumoto; Kenji Kawakami; Hironori Masaki; Tsuyoshi Nagatake; Yoshiko Sueyasu; Tomoaki Iwanaga; Hisamichi Aizawa; Kazunori Oishi
Journal:  Clin Vaccine Immunol       Date:  2006-12-13

Review 3.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

4.  The evolution of greater humoral immunity in females than males: implications for vaccine efficacy.

Authors:  Ashley L Fink; Sabra L Klein
Journal:  Curr Opin Physiol       Date:  2018-03-29

5.  Antibody response to pneumococcal vaccination as a function of preimmunization titer.

Authors:  Nathaniel D Hare; Brian J Smith; Zuhair K Ballas
Journal:  J Allergy Clin Immunol       Date:  2008-10-25       Impact factor: 10.793

6.  Sex- and Gender-Based Pharmacological Response to Drugs.

Authors:  Franck Mauvais-Jarvis; Heiner K Berthold; Ilaria Campesi; Juan-Jesus Carrero; Santosh Dakal; Flavia Franconi; Ioanna Gouni-Berthold; Mark L Heiman; Alexandra Kautzky-Willer; Sabra L Klein; Anne Murphy; Vera Regitz-Zagrosek; Karen Reue; Joshua B Rubin
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

7.  The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy.

Authors:  Enrica Riva; Filippo Salvini; Maria Laura Garlaschi; Giovanni Radaelli; Marcello Giovannini
Journal:  BMC Infect Dis       Date:  2012-05-03       Impact factor: 3.090

Review 8.  How sex and age affect immune responses, susceptibility to infections, and response to vaccination.

Authors:  Carmen Giefing-Kröll; Peter Berger; Günter Lepperdinger; Beatrix Grubeck-Loebenstein
Journal:  Aging Cell       Date:  2015-02-26       Impact factor: 9.304

9.  A case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine.

Authors:  C R Laratta; K Williams; D Vethanayagam; M Ulanova; H Vliagoftis
Journal:  Allergy Asthma Clin Immunol       Date:  2017-06-07       Impact factor: 3.406

Review 10.  The Confluence of Sex Hormones and Aging on Immunity.

Authors:  Melanie R Gubbels Bupp; Tanvi Potluri; Ashley L Fink; Sabra L Klein
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.